West Sacramento Clinic

The Methadone Maintenance Program provides long-term medication-assisted treatment for opioid dependence. Methadone helps stabilize the brain, reduce withdrawal symptoms, decrease cravings, and block the euphoric effects of opioids such as heroin or fentanyl when an adequate dose is reached.

Buprenorphine treatment helps relieve opioid withdrawal symptoms, reduce cravings, and block the effects of other opioids so patients can stabilize and move forward in recovery. This medication-assisted treatment program is supported by medical care, counseling, drug testing, naloxone access, referrals, and long-term recovery planning.

The Long-Term Detox Program uses methadone or buprenorphine over a six-month period to help patients stabilize first, then gradually taper from medication with clinical support. The program includes counseling, on-site groups, referrals, naloxone access, limited medical services, and discharge planning.

Sublocade is a once-monthly extended-release injection form of buprenorphine. It provides sustained medication coverage throughout the month, helps reduce cravings and withdrawal symptoms, blocks the rewarding effects of opioids, and supports medication adherence for eligible patients.

Vivitrol is an injectable extended-release form of naltrexone administered once every four weeks. It blocks incoming opioids, may reduce drug cravings, reduces alcohol cravings, and supports medication adherence for eligible patients who have already completed the required opioid-free period.